Cite
Hirsch M, Steigbigel R, Staszewski S, et al. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy. J Infect Dis. 1999;180(3):659-65doi: 10.1086/314948.
Hirsch, M., Steigbigel, R., Staszewski, S., Mellors, J., Scerpella, E., Hirschel, B., Lange, J., Squires, K., Rawlins, S., Meibohm, A., & Leavitt, R. (1999). A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy. The Journal of infectious diseases, 180(3), 659-65. https://doi.org/10.1086/314948
Hirsch, M, et al. "A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy." The Journal of infectious diseases vol. 180,3 (1999): 659-65. doi: https://doi.org/10.1086/314948
Hirsch M, Steigbigel R, Staszewski S, Mellors J, Scerpella E, Hirschel B, Lange J, Squires K, Rawlins S, Meibohm A, Leavitt R. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy. J Infect Dis. 1999 Sep;180(3):659-65. doi: 10.1086/314948. PMID: 10438352.
Copy
Download .nbib
